TransMedics Group (TMDX) Competitors $121.31 -3.40 (-2.73%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$121.75 +0.44 (+0.36%) As of 05/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMDX vs. SOLV, SNN, PEN, STVN, GKOS, NARI, IRTC, INSP, BLCO, and SLNOShould you be buying TransMedics Group stock or one of its competitors? The main competitors of TransMedics Group include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry. TransMedics Group vs. Solventum Smith & Nephew Penumbra Stevanato Group Glaukos Inari Medical iRhythm Technologies Inspire Medical Systems Bausch + Lomb Soleno Therapeutics Solventum (NYSE:SOLV) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, community ranking, profitability, risk and earnings. Do institutionals and insiders hold more shares of SOLV or TMDX? 99.7% of TransMedics Group shares are owned by institutional investors. 0.1% of Solventum shares are owned by insiders. Comparatively, 7.0% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to SOLV or TMDX? In the previous week, Solventum had 14 more articles in the media than TransMedics Group. MarketBeat recorded 21 mentions for Solventum and 7 mentions for TransMedics Group. Solventum's average media sentiment score of 1.36 beat TransMedics Group's score of 1.21 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 15 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor SOLV or TMDX? TransMedics Group received 113 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 59.28% of users gave TransMedics Group an outperform vote while only 7.41% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes27.41%Underperform Votes2592.59% TransMedics GroupOutperform Votes11559.28% Underperform Votes7940.72% Is SOLV or TMDX more profitable? TransMedics Group has a net margin of 8.14% compared to Solventum's net margin of 0.00%. TransMedics Group's return on equity of 18.74% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A TransMedics Group 8.14%18.74%4.39% Which has stronger earnings & valuation, SOLV or TMDX? Solventum has higher revenue and earnings than TransMedics Group. Solventum is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.31B1.52$373.71M$2.1633.72TransMedics Group$488.23M8.40-$25.03M$1.3689.20 Do analysts recommend SOLV or TMDX? Solventum currently has a consensus price target of $80.29, suggesting a potential upside of 10.22%. TransMedics Group has a consensus price target of $126.70, suggesting a potential upside of 4.44%. Given Solventum's higher probable upside, equities research analysts clearly believe Solventum is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.10TransMedics Group 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.82 SummaryTransMedics Group beats Solventum on 12 of the 18 factors compared between the two stocks. Get TransMedics Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TMDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMDX vs. The Competition Export to ExcelMetricTransMedics GroupElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.10B$3.26B$5.37B$8.39BDividend YieldN/A1.73%5.22%4.10%P/E Ratio129.0516.6026.8419.71Price / Sales8.4085.43392.34117.39Price / Cash530.0844.0938.2534.62Price / Book28.883.736.794.50Net Income-$25.03M$94.03M$3.23B$248.18M7 Day Performance-0.41%0.75%1.53%0.20%1 Month Performance33.00%20.87%10.06%12.37%1 Year Performance-11.43%-12.91%16.72%7.04% TransMedics Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMDXTransMedics Group1.3185 of 5 stars$121.31-2.7%$126.70+4.4%-12.4%$4.10B$488.23M129.05210Positive NewsSOLVSolventum2.0027 of 5 stars$75.81+2.3%$80.29+5.9%+19.0%$13.12B$8.31B35.1022,000Positive NewsAnalyst UpgradeSNNSmith & Nephew2.2242 of 5 stars$29.09+0.7%$28.00-3.7%+11.0%$12.74B$5.81B13.4720,100News CoveragePENPenumbra4.7111 of 5 stars$280.89+0.1%$302.40+7.7%+35.0%$10.88B$1.24B826.153,900Positive NewsSTVNStevanato Group1.2945 of 5 stars€24.64+2.6%N/A+24.6%$7.46B$1.12B52.434,650Positive NewsGKOSGlaukos4.6175 of 5 stars$95.78+0.3%$134.67+40.6%-12.5%$5.47B$404.52M-33.37780Positive NewsNARIInari Medical0.5692 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800IRTCiRhythm Technologies1.2741 of 5 stars$141.51+0.4%$128.55-9.2%+52.9%$4.52B$618.59M-38.881,790Positive NewsINSPInspire Medical Systems4.672 of 5 stars$149.86-1.8%$211.91+41.4%-4.0%$4.42B$840.11M86.62760Positive NewsGap UpBLCOBausch + Lomb4.1389 of 5 stars$11.76flat$15.50+31.8%-22.8%$4.16B$4.83B-12.9212,500Gap UpSLNOSoleno Therapeutics4.8514 of 5 stars$75.29+0.4%$106.78+41.8%+65.6%$3.79BN/A-22.6830News CoveragePositive News Related Companies and Tools Related Companies Solventum Alternatives Smith & Nephew Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Inari Medical Alternatives iRhythm Technologies Alternatives Inspire Medical Systems Alternatives Bausch + Lomb Alternatives Soleno Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMDX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransMedics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransMedics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TMDX Stock Free TMDX Stock Alerts